Llwytho...
Enhanced protection against Ebola virus mediated by an improved adenovirus-based vaccine.
The Ebola virus is transmitted by direct contact with bodily fluids of infected individuals, eliciting death rates as high as 90% among infected humans. Currently, replication defective adenovirus-based Ebola vaccine is being studied in a phase I clinical trial. Another Ebola vaccine, based on an at...
Wedi'i Gadw mewn:
Prif Awduron: | , , , , , , |
---|---|
Fformat: | Artigo |
Iaith: | Inglês |
Cyhoeddwyd: |
Public Library of Science (PLoS)
2009-01-01
|
Cyfres: | PLoS ONE |
Mynediad Ar-lein: | http://europepmc.org/articles/PMC2669164?pdf=render |
Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|